FDA denies emergency use nod for Covaxin in US

New Delhi: The US Food and Drug administration has denied approval for emergency use of Bharat Biotech’s Covaxin, and has asked for additional data, biopharmaceutical Ocugen, the US partner of the Indian vaccine maker has said.

FDA recommended that Ocugen “pursue a Biologics Licence Application (BLA) submission instead of an EUA application” and “requested additional information and data”. Ocugen anticipates that data from additional clinical trials will be needed to support the submission. “We were close to finalising our EUA application when we received (FDA’s) recommendation to pursue a BLA path. While this will extend our timelines, we are committed to bringing Covaxin to the US,” said Ocugen’s Shankar Musunuri. agencies

  • Related Posts

    Operation Monsoon Thunder: NCB raids four cities, arrests six in probe into US-bound opioid and psychotropic drug shipments

    New Delhi: In a sweeping international crackdown, the Narcotics Control Bureau (NCB) and the US Drug Enforcement Administration (DEA) have dismantled the Indian nerve center of a massive transnational drug…

    Maharashtra FDA issues statewide compliance order for health supplements, nutraceuticals

    Commissioner of Food Safety Tukaram Mundhe said inspections, consumer complaints and surveillance had repeatedly revealed violations Repeated violations of existing food safety regulations by manufacturers and sellers of health supplements…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Operation Monsoon Thunder: NCB raids four cities, arrests six in probe into US-bound opioid and psychotropic drug shipments

    Operation Monsoon Thunder: NCB raids four cities, arrests six in probe into US-bound opioid and psychotropic drug shipments

    Maharashtra FDA issues statewide compliance order for health supplements, nutraceuticals

    Maharashtra FDA issues statewide compliance order for health supplements, nutraceuticals

    Karnataka High Court quashes case against MedPlus over short supply of one tablet costing ₹1.12

    Karnataka High Court quashes case against MedPlus over short supply of one tablet costing ₹1.12

    Fake epilepsy, diabetes drugs made using chalk, lactose at illegal Himachal factory; 2 held

    Fake epilepsy, diabetes drugs made using chalk, lactose at illegal Himachal factory; 2 held

    Without Skipping a Beat: Surgical Robot SSiMantra powers Landmark Beating Heart Bypass

    Without Skipping a Beat: Surgical Robot SSiMantra powers Landmark Beating Heart Bypass

    Drug Department Raids Patna’s Govind Mitra Road Medicine Market Over Suspected Illegal Sale Of Medicines

    Drug Department Raids Patna’s Govind Mitra Road Medicine Market Over Suspected Illegal Sale Of Medicines